Preoperative left ventricular hypertrophy is associated with reduced patient survival after liver transplantation

Clinical Transplantation

Volumn 28, Issue 2, 2014, Pages 236-242

  Darstein, F ^a   Konig C ^a   Hoppe Lotichius, M ^a   Grimm, D ^a   Knapstein, J ^a   Mittler, J ^a   Zimmermann, A ^a   Otto, G ^a   Lang, H ^a   Galle, P R ^a   Zimmermann, T ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Cirrhosis; Cirrhotic cardiomyopathy; Left ventricular hypertrophy; Liver transplantation; Survival

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HUMAN; HYPERTENSION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

CIRRHOSIS; CIRRHOTIC CARDIOMYOPATHY; LEFT VENTRICULAR HYPERTROPHY; LIVER TRANSPLANTATION; SURVIVAL;

FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 84893445937     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12304     Document Type: Article

References (38)

1. Adam R, Karam V, Delvart V et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol 2012: 57: 675.
2. Møller S, Hove JD, Dixen U, Bendtsen F. New insights into cirrhotic cardiomyopathy. Int J Cardiol 2012: 167: 1101.
3. Lee SS. Cardiac abnormalities in liver cirrhosis. West J Med 1989: 151: 530.
4. Zardi EM, Abbate A, Zardi DM et al. Cirrhotic cardiomyopathy. J Am Coll Cardiol 2010: 56: 539.
5. de Marco M, Chinali M, Romano C et al. Increased left ventricular mass in pre-liver transplantation cirrhotic patients. J Cardiovasc Med (Hagerstown) 2008: 9: 142.
6. Donovan CL, Marcovitz PA, Punch JD et al. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 1996: 61: 1180.
7. Ortiz-Olvera NX, Castellanos-Pallares G, Gómez-Jiménez LM et al. Anatomical cardiac alterations in liver cirrhosis: an autopsy study. Ann Hepatol 2011: 10: 321.
8. Pouriki S, Alexopoulou A, Chrysochoou C et al. Left ventricle enlargement and increased systolic velocity in the mitral valve are indirect markers of the hepatopulmonary syndrome. Liver Int 2011: 31: 1388.
9. Verdecchia P, Schillaci G, Borgioni C et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 1995: 25: 871.
10. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986: 57: 450.
11. Liao Y, Cooper RS, Durazo-Arvizu R, Mensah GA, Ghali JK. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997: 29: 641.
12. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 2006: 43: S121.
13. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993: 75: 977.
14. Dzau VJ. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993: 153: 937.
15. Harrap SB, Dominiczak AF, Fraser R et al. Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults. Circulation 1996: 93: 1148.
16. Drazner MH, Dries DL, Peshock RM et al. Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension 2005: 46: 124.
17. Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003: 115: 41.
18. Pierdomenico SD, Lapenna D, Cuccurullo F. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension. Am J Hypertens 2008: 21: 464.
19. Milani A, Zaccaria R, Bombardieri G, Gasbarrini A, Pola P. Cirrhotic cardiomyopathy. Dig Liver Dis 2007: 39: 507.
20. Bansal S, Lindenfeld J, Schrier RW. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Circ Heart Fail 2009: 2: 370.
21. Murro DG, Beavers M, Harshfield GA, Kapuku GK. Aldosterone contributes to elevated left ventricular mass in black boys. Pediatr Nephrol 2013: 28: 655.
22. Weber KT. Aldosterone in congestive heart failure. N Engl J Med 2001: 345: 1689.
23. Félix-Redondo FJ, Fernández-Bergés D, Calderón A, Consuegra-Sánchez L, Lozano L, Barrios V. Prevalence of left-ventricular hypertrophy by multiple electrocardiographic criteria in general population: Hermex study. J Hypertens 2012: 30: 1460.
24. Movahed M, Bates S, Strootman D, Sattur S. Obesity in adolescence is associated with left ventricular hypertrophy and hypertension. Echocardiography 2011: 28: 150.
25. Powell BD, Redfield MM, Bybee KA, Freeman WK, Rihal CS. Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease. Am J Cardiol 2006: 98: 116.
26. Glassock RJ, Pecoits-Filho R, Barberato SH. Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 2009: 4(Suppl 1): S79.
27. Zhai Y, Zhou G, Deng G et al. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers. Gastroenterology 2006: 130: 2001.
28. Leibowitz D, Dresner-Pollak R, Dvir S, Rokach A, Reznik L, Pollak A. Association of an estrogen receptor-alpha gene polymorphism with left ventricular mass. Blood Press 2006: 15: 45.
29. Saxena NK, Fu PP, Nagalingam A et al. Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. Gastroenterology 2010: 139: 1762, 1773.e1-5.
30. Sam F, Duhaney T-S, Sato K et al. Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure. Endocrinology 2009: 151: 322.
31. Habib S, Berk B, Chang CH et al. MELD and prediction of post-liver transplantation survival. Liver Transpl 2006: 12: 440.
32. Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Møller S. Arterial compliance in patients with cirrhosis: stroke volume-pulse pressure ratio as simplified index. Am J Physiol Gastrointest Liver Physiol 2001: 4: G584.
33. Verdecchia P, Porcellati C, Reboldi G et al. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 2001: 104: 2039.
34. Wong F. Cirrhotic cardiomyopathy. Hepatol Int 2009: 3: 294.
35. Weiner MM, Reich DL, Lin HM, Krol M, Fischer GW. Influence of increased left ventricular myocardial mass on early and late mortality after cardiac surgery. Br J Anaesth 2013: 110: 41.
36. Piscaglia F, Zironi G, Gaiani S et al. Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study. Hepatology 1999: 30: 58.
37. Therapondos G, Flapan AD, Dollinger MM, Garden OJ, Plevris JN, Hayes PC. Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus. Liver Transpl 2002: 8: 690.
38. Torregrosa M, Aguadé S, Dos L et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol 2005: 42: 68.